About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Schizophrenia Clinical Trials in Chicago | 193 Studies

Clinical Trials SchizophreniaChicago

Schizophrenia Clinical Trials in Chicago

Find 193 clinical trials for schizophrenia near Chicago, Illinois. Connect with research centers in your area.

All Schizophrenia trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-80 of 193 trials

CompletedStudy to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005Lyndra Therapeutics, Inc. is developing LYN-005, a long-acting oral (LAO) capsule (LYNX™ dosage form) of risperidone.NCT05779241·Garden Grove, California and 4 others CompletedAripiprazole Open-Label, Safety and Tolerability StudyThe purpose of this study is to test the long-term safety and tolerability of aripiprazole in adolescent patients with schizophrenia, and child and adolescent patients with…NCT00102518·Birmingham, Alabama and 49 others

Schizophrenia Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With SchizophreniaThis study will evaluate the safety and tolerability of aripiprazole lauroxil (also known as ARISTADA, ALKS 9070).NCT02634320·Little Rock, Arkansas and 17 others

CompletedA Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label, Long-Term Safety Phase to Evaluate the Efficacy and Safety of TV-44749 in Adults With SchizophreniaThe primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia.NCT05693935·Bentonville, Arkansas and 81 others

CompletedHomeless Youth Study - Stepping Stone 2.0Housing instability is both a cause and consequence of mental health problems.NCT03776422·Chicago, Illinois

CompletedA Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic MedicationThe purpose of this study was to evaluate the efficacy of ASP4345 on cognitive impairment compared to placebo using change from baseline in MATRICS Consensus Cognitive Battery…NCT03557931·Cerritos, California and 26 others

CompletedOpen-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral AripiprazoleThe purpose of this study is to determine the usability of the Medical Information Device #1 (MIND1) system in adults with schizophrenia who are treated with oral aripiprazole.NCT02219009·Cerritos, California and 5 others

CompletedEfficacy Study of Early Onset of Antipsychotic Drug Action in SchizophreniaThe current study has been designed to address the significance of early onset of response prospectively in patients treated with an atypical antipsychotic.NCT00337662·Little Rock, Arkansas and 33 others

CompletedEfficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderThe purposes of this study are to assess the efficacy, safety, and side effects among doses approved by the Food and Drug Administration and higher (not FDA approved) doses of…NCT00100776·Anaheim, California and 32 others

CompletedA Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of SchizophreniaThis is a Phase 3, 6-week, randomized, double-blind, placebo-controlled, multicenter, outpatient study in subjects with schizophrenia with an inadequate response to their current…NCT05145413·Phoenix, Arizona and 165 others

CompletedA Study of the Efficacy (Effectiveness) of Paliperidone Palmitate in the Prevention of Recurrence of the Symptoms of Schizophrenia.The purpose of this study is to evaluate the efficacy of paliperidone palmitate compared with placebo in the prevention of recurrence of the symptoms of schizophrenia and to…NCT00111189·Little Rock, Arkansas and 54 others

CompletedLong Term Study of RBP 7000 in the Treatment of Subjects With SchizophreniaThis is a Phase 3, open label study administering RBP-7000 in the treatment of patients with schizophrenia.NCT02203838·Little Rock, Arkansas and 47 others

CompletedEffects of Risperdal Consta on Ability to Benefit From Social Skills Training in SchizophreniaThe specific aim of this study is to determine whether the new, long-acting, form of risperidone, Risperdal Consta, improves the ability of schizophrenia patients to benefit from…NCT00148083·Chicago, Illinois and 1 other

CompletedAn Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in de novo subjects with…NCT04820309·Little Rock, Arkansas and 116 others

CompletedComparing Mobile Health (mHealth) and Clinic-Based Self-Management Interventions for Serious Mental IllnessThe study is a three year research project whose aims are to evaluate the willingness of individuals with serious mental illness to initiate the two illness self-management…NCT02421965·Chicago, Illinois

CompletedA Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic PatientsThe primary objective of this study was to assess time to discontinuation due to lack of tolerability among patients with schizophrenia receiving LY2140023, given orally twice…NCT00845026·Escondido, California and 22 others

CompletedTreatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)The primary aim of this study is to determine the safety and efficacy of quetiapine (Seroquel) for the treatment of psychosis and/or agitation in patients with primary dementia…NCT00043849·Birmingham, Alabama and 20 others

CompletedA Combination of Two Currently Approved Drugs to Enhance the Treatment of SchizophreniaStudy of a medication for the treatment of Schizophrenia in patients who are already taking Abilify, Risperdal, Seroquel, ZyprexaNCT00089869·Cerritos, California and 19 others

CompletedEfficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of the negative symptoms of schizophreniaNCT02970305·Phoenix, Arizona and 100 others

CompletedEfficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With SchizophreniaThe objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.NCT00654706·Garden Grove, California and 25 others

PreviousPage 4 of 10Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia